With talk of Bubble 2.0 bubbling up everywhere, maybe tech companies could take some cues from biotechs -- they're used to reinventing themselves.
Biotechs Rise from the Ashes
With talk of Bubble 2.0 bubbling up everywhere, maybe tech companies could take some cues from biotechs — they’re used to reinventing themselves. "There are only two kinds of biotech companies — those that have haddisappointments and those that will … in the future." — Ted Love, Nuvelo CEO. When clinical trial results just say […]
